CD4 and myeloid sarcoma: The literature supports both a pathogenic (72–82) and regulatory (76, 83–94) role for B-cells in MS/EAE, and it is intriguing to speculate about the potential immune cell interplay between CD4+ T-cells, B-cells, and CD8+ T-cells therein.